THE PREPARATION OF FRUCTOSE-MODIFIED CHITOSAN MICROCARRIERS AND CULTURE OF PRIMARY RAT HEPATOCYTES

1. INTRODUCTION The development of cell based organs and tissue-engineering devices such as hybrid artificial liver requires a large number of cells be cultured for the replacement of damaged tissue [1,2]. Since its introduction in 1967, microcarriers culture has been applied successfully in growing primary cells and cell lines with the advantage of attaining high cell density [3,4]. Spheroid culture is another promising hepatocytes culture method to enhance the cell density and metaboli…     

乳糖修饰壳聚糖微载体的制备及对培养肝细胞代谢活性的影响

液体石蜡作分散介质。戊二醛作交联刑，通过反相悬浮聚合制备了微米级的壳聚糖微载体．环氧氟丙烷活化后，乳糖进行修饰．用孔糖修饰的微载体进行原代大鼠肝细胞培养，利用相差显微镜对培养细胞进行形态观察，并测定肝细胞的代谢活性，结果显示，乳糖修饰壳聚糖微载体是一种优良的肝细胞培养支架．     

微载体糖基化修饰及培养基中添加果糖对大鼠原代肝细胞体外培养的影响

采用对大孔壳聚糖微载体进行糖基化修饰和培养基中添加果糖两种方式考察了果糖对原代大鼠肝细胞体外培养的影响。结果显示,肝细胞在果糖修饰大孔微载体上聚集生长,形态良好,保持了较高的白蛋白分泌和尿素合成活性,表明果糖修饰大孔壳聚糖微载体是较理想的细胞培养支架材料。培养基中加入果糖,肝细胞乳酸脱氢酶泄漏明显降低,白蛋白分泌与尿素合成活性进一步提高,显示有利于受损细胞功能的恢复。     

Antibacterial mechanism of chitosan microspheres in a solid dispersing system against E. coli

In this study, we investigated the antibacterial mechanism through the interfacial contacting inhibition behaviors of chitosan antimicrobials against Escherichia coli in solid dispersing state. Chitosan microspheres (CMs) were prepared by emulsification cross-linking reaction, and oleoyl-CMs (OCMs) were obtained by introduction of oleoyl groups to the chitosan. The CMs were with smooth surface and spherical shape of diameter of about 124 microm. The antibacterial activity was directly proportional to the concentration and the hydrophobic property of CMs. The fluorescence experiments indicated CMs had influenced the structure of membrane, especially the OCMs were speculated to interact with proteins on the cell membrane. SEM photographs showed E. coli adhered to the surface of the CMs and provided evidences for the disruption of the cells, while the bacterium conglomerated on the surface of the OCMs. The CMs changed the permeability of membrane and caused cellular leakage that correlated with the hydrophobic interaction between CMs and cytoplasmic membrane phospholipids of Gram-negative bacteria. Solid dispersing system makes the antibacterial activities of CMs counted as a sequent event-driven to study the antibacterial mechanism of chitosan originally.     

肾上腺髓质素微球复合PLGA/纳米羟基磷灰石支架材料的制备及生物活性评价

利用离子乳化交联法制备了负载肾上腺髓质素的壳聚糖微球,应用热致相分离法制备了乳酸和乙醇酸共聚物/纳米羟基磷灰石(PLGA/nHA)支架材料并在其中包覆载药微球.通过扫描电子显微镜、体外释放行为、材料溶血行为、碱性磷酸酶(ALP)活性的测定、支架材料表面细胞荧光染色和MTT[3-(4,5-二甲基噻唑-2)-2,5-二苯基四氮唑溴盐]比色法等手段综合评价载药支架材料的性能及生物活性.结果表明,微球直径均匀,载药支架孔径大小合适并相互穿通.支架材料的溶血率小于5%,符合医用材料的溶血实验要求.载药支架及支架材料本身对成骨细胞及血管内皮细胞的增殖以及成骨细胞的分化均有一定的促进作用.     

In vitro degradation and release behavior of porous poly(lactic acid) scaffolds containing chitosan microspheres as a carrier for BMP-2-derived synthetic peptide

To develop a novel tissue engineering scaffold with the capability of controlled releasing BMP-2-derived synthetic peptide, porous poly(lactic acid)/chitosan microspheres (PLA/CMs) composites containing different quantities of chitosan microspheres were prepared by a thermally induced phase separation method. FTIR analysis revealed that there were strong hydrogen bond interactions between the PLA and chitosan component. Introduction of less than 30% CMs (on PLA weight basis) did not remarkably affect the morphology and porosity of the PLA/CMs scaffolds. The compressive strength of the composite scaffolds increased from 0.48 to 0.66 MPa, while the compressive modulus increased from 7.29 to 8.23 MPa as the microspheres' contents increased from 0% to 50%. In vitro degradability investigation indicated that the dissolution of chitosan component was preferential than PLA matrix and the inclusion of CMs could neutralize the acidity of PLA degradation products. Compared with the rapid release from CMs, the synthetic peptide was released from PLA/CMs scaffolds in a temporally controlled manner, mainly depending on the degradation of PLA matrix. The promising microspheres based scaffold release system can be used to deliver bioactive factors for a variety of non-loaded bone regeneration and tissue engineering application.     

原代大鼠肝细胞在多孔壳聚糖及其复合物支架上的培养

研究了原代肝细胞在壳聚糖及其复合物多孔支架上的生长及代谢.结果表明,细胞在多孔壳聚糖支架上生长良好,且密度、代谢活性较单层培养条件下有大幅度提高,细胞在7d后仍能保持较强的分泌白蛋白和合成尿素的功能,壳聚糖复合物上肝细胞的代谢活性更高.还从材料的化学结构和几何形态角度对这种材料的优势进行了讨论.     

巯基化改性壳聚糖在电化学生物传感器制备中的应用

以壳聚糖、N-乙酰-L-半胱氨酸(NAC)为原料,以1-羟基苯并三唑(HOBt)和1-乙基-3-(3-二甲基胺丙基)碳化二亚胺盐酸盐(EDAC)为缩合剂,合成功能化壳聚糖衍生物巯基壳聚糖(CHS-NAC).用红外光谱(FTIR)、核磁共振(1H-NMR)及X射线衍射(XRD)对其结构进行表征,用Ellman’s试剂通过标准曲线法测得巯基含量.利用CHS-NAC的黏附性,通过层层吸附的方法将CHS-NAC、纳米金及细胞色素c分别修饰到玻碳电极(GC)上,通过扫描电子显微镜(SEM)对修饰电极表面的形貌进行了观察,采用循环伏安和电化学阻抗研究了不同修饰膜电极的电化学行为,及扫描速率对细胞色素c修饰电极的影响,并开展了对过氧化氢的电催化分析.实验结果表明,CHS-NAC能高效地将纳米金及细胞色素c固定在电极表面,并能有效发挥纳米金辅助转移电子及细胞色素c对过氧化氢催化的能力.     

异相法制备磺酸基取代壳聚糖衍生物

用3-氯-2-羟基丙磺酸钠与壳聚糖在较低温度下进行非均相反应制备了一系列取代度,结构新颖的改性壳聚糖.实验表明化学改性能极大的提高壳聚糖在水溶液中的溶解性能.研究了不同的反应条件对壳聚糖取代度的影响并用核磁共振表征了它们的结构.反应可在中性、较为温和的条件下进行,通过改变反应时间和反应物比例能有效的控制改性壳聚糖的取代度.改性后的壳聚糖能溶解于中性的水溶液中,浊度实验表明产物具有明显的两性聚电解质特征,其等电点约在pH=5.7.该方法为制备化学改性壳聚糖的一种有效的方法.     

壳聚糖超声可控降解及降解动力学研究

通过正交实验法考察了壳聚糖溶液浓度、反应温度、超声强度以及醋酸溶液浓度对超声降解反应的影响,确定了最佳反应条件,制备了一系列不同分子量的壳聚糖.研究了壳聚糖溶液浓度、反应温度以及壳聚糖原料分子参数与降解速率常数的关系.通过红外光谱、X-射线衍射和凝胶渗透色谱对降解产物进行了表征.结果表明,超声降解壳聚糖的最佳条件为10℃,壳聚糖溶液浓度2.5g/L.降解速率常数随壳聚糖溶液浓度和反应温度的降低而增大.高分子量和低脱乙酰度的壳聚糖原料有较高的降解速率和降解速率常数,壳聚糖原料的分子量对降解速率和降解速率常数的影响大于脱乙酰度对其的影响.超声波导致了壳聚糖分子量的降低和产物晶体结构的破坏,但没有改变产物的脱乙酰度和糖残基结构.     

多层面验证共培养微环境诱导法诱导骨髓间充质干细胞心肌样分化

为了多层面探讨共培养微环境诱导法定向诱导骨髓间充质干细胞(MSCs)心肌样分化的可行性,取第3代MSCs与原代心肌细胞(CMs)进行共培养。在显微镜下观察诱导1周后的MSCs形态学变化,用免疫荧光和实时荧光定量聚合酶链式反应(RT-PCR)分别检测诱导的MSCs中心肌肌钙蛋白I(cTnI)、α-肌动蛋白(α-actin)、Nkx-2.5和GATA-4的基因表达变化情况。采用超高效液相色谱-串联质谱(UPLC-MS/MS)分别检测诱导组和对照组的代谢产物。诱导1周后的MSCs形态呈心肌样改变,cTnI、α-actin、Nkx-2.5和GATA-4的基因表达均明显升高,正交偏最小二乘法判别分析(OPLS-DA)模型显示诱导的MSCs代谢物向CMs转变趋势明显。通过多元和单元统计分析筛选差异变量,根据一级质谱和二级质谱比对结果,最终确定12种差异代谢物。与未经诱导的MSCs相比,经诱导的MSCs与CMs中变化趋势相同的差异代谢物有7种,变化趋势不同的差异代谢物有5种。实验结果表明,无论从形态、基因、蛋白质还是代谢层面看,MSCs通过与CMs间接接触共培养后均发生了心肌样改变,但是与CMs仍存在差异。     

超声波辐射制备羧甲基壳聚糖

应用超声波辐射方法制备水溶性的羧甲基壳聚糖,利用胶体滴定法测定产物中羧基含量,探讨超声波作用下,反应时间、反应温度及反应物投料比对羧甲基化程度的影响。结果表明,在其它反应条件相同时,使用超声波辐射比使用机械搅拌提高羧甲基取代程度,反应时间缩短５ｈ。     

烷基化壳聚糖纳米微球的制备及其XPS光谱分析

在碱性条件下通过卤代烃的N-烷基取代反应制备得到烷基壳聚糖衍生物,红外光谱表明,烷基取代反应主要发生在壳聚糖的氨基上,并通过x射线光电子能谱测试定量分析了烷基在壳聚糖各个官能团上的分布.动态光散射研究表明,该衍生物在水中可自动形成粒径在10nm～200nm范围的纳米微粒.     

Properties and adsorptive capacity of amino acids modified chitosans for copper ion removal

This work presents the results of the modification of lateral groups of chitosan (2-amino-2-desoxy-β-D-glucose) by the reaction with different amino acids (glycine, L-lysine, -glutamic acid and L-isoleucine) under acid catalysis. The Cu²⁺ adsorption capacity of pure chitosan and of the chemically modified chitosans were also evaluated. The modification reaction favored the amide formation of the C-2 carbon of the glycoside ring under the adopted reaction conditions: reaction time and temperature and using sulfuric acid as a catalyst. The Cu²⁺ adsorption kinetics and equilibrium response using pure chitosan and the chemically modified chitosans as adsorbents showes that the adsorption capacity of equilibrium depended on the initial ion concentration. The response of each adsorbent gave good correlation with Langmuir's isotherm model. The following maximum adsorption capacity constants were obtained: 172.4 mg/g for chitosan and 69.9, 34.4, and 26.7 mg/g for modified chitosan with glycine, L-glutamic acid, and L-lysine, respectively. The adsorptive capacity seems to be dependent on the length and complexity of the added group.     

羧甲基香菇多糖表面修饰的聚乳酸材料的表面性能研究

制备了香菇多糖羧甲基衍生物,再通过化学接枝方法利用共价键将羧甲基香菇多糖固定在氨基化聚乳酸基材表面,得到羧甲基香菇多糖化学接枝修饰的聚乳酸材料.此外,通过在氨基化聚乳酸基材表面进行羧甲基香菇多糖与壳聚糖的层层自组装,得到生物多糖层层自组装修饰的聚乳酸材料.采用扫描电子显微镜、水接触角测量仪、抗菌活性测试、溶血试验和血栓试验等方法对被修饰聚乳酸材料的表面性能和生物性能进行了分析和比较.结果表明采用2种表面修饰方法得到的羧甲基香菇多糖修饰的聚乳酸材料的亲水性、血液相容性以及对大肠杆菌抗菌活性得到改善.与化学接枝方法相比,经过羧甲基香菇多糖与壳聚糖层层自组装修饰的聚乳酸材料具有更好的亲水性、血液相容性和抗菌活性.     

Ionic conductivity and tensile properties of hydroxyethyl and hydroxypropyl chitosan membranes

Hydroxyethyl chitosan and hydroxypropyl chitosan were prepared through the reaction of alkali‐chitosan with 2‐chloroethanol and propylene epoxide, respectively. Fourier transform infrared and ¹³C NMR measurements were made to examine the substitution on the chitosan unit. According to a comparison of the peak areas between the modified chitosan and unmodified chitosan and the integration of peak areas of ¹H NMR spectra, for both modified chitosans, the maximum degree of substitution was less than 25%. The ionic conductivity and mechanical properties of modified chitosan membranes were investigated. In comparison with the unmodified chitosan membrane, hydrated hydroxyethyl and hydroxypropyl chitosan membranes with a higher degree of substitution showed an increase in ionic conductivity of about one order of magnitude; moreover, the crystallinity of hydroxyethyl and hydroxypropyl chitosan membranes was remarkably reduced, and their swelling indices increased significantly. However, these modified membranes did not exhibit significant changes in their tensile strength and breaking elongation. © 2004 Wiley Periodicals, Inc. J Polym Sci Part B: Polym Phys 42: 1379–1397, 2004     

Biomimetic modification of chitosan with covalently grafted lactose and blended heparin for improvement of in vitro cellular interaction

Lactose‐ and heparin‐modified chitosan films were prepared and their physical and biological properties were compared with chitosan, chitosan‐g‐heparin, and chitosan‐g‐lactose films. Atomic force microscopy (AFM) measurement showed that all these films in the dry state were rather flat with a roughness smaller than 20 nm. While the chitosan‐g‐lactose/heparin and chitosan‐g‐lactose films have the highest swelling and weight loss ratios, the chitosan and chitosan‐g‐heparin films have the lowest. The chitosan‐g‐lactose/heparin film showed stronger ability to induce chondrocyte attachment, proliferation, viability, and glycosaminoglycan (GAG) secretion than that of the chitosan, chitosan‐g‐heparin, and chitosan‐g‐lactose films. Chondrocyte aggregates and nodules were observed on the chitosan‐g‐lactose/heparin and chitosan‐g‐lactose films, which still preserved viable metabolic ability. These results show that the lactose‐modified and heparin‐incorporated chitosan film can enhance the cell–biomaterial interaction synchronously. The resulting chitosan‐g‐lactose/heparin material is more bioactive that might be applicable as promising scaffold for chondrogenesis. Copyright © 2007 John Wiley & Sons, Ltd.     

氨基酸修饰壳聚糖对胆固醇的吸附作用

通过将不同脱乙酰度的壳聚糖粉末与戊二醛交联,再经苯丙氨酸和色氨酸修饰,得到了两种珠状壳聚糖吸附剂,并进而研究了有关吸附剂对胆因醇的吸附性能。实验表明,交联壳聚糖珠对ＣＨＯ的吸附能力比壳聚糖粉末降低,而经不同氨基酸修饰后的壳聚糖珠对ＣＨＯ吸附能力提高,用Ｐｈｅ修饰比用Ｔｒｙ修饰的珠吸附性能更好些。     

壳聚糖包裹硅胶载体印迹牛血红蛋白的研究

用壳聚糖包裹的硅胶为载体, 利用壳聚糖表面的氨基与戊二醛结合, 在硅胶表面引入醛基, 固定模板蛋白(牛血红蛋白). 用溶胶-凝胶过程再次包裹固定蛋白质的载体, 洗去模板蛋白后, 得到具有选择性识别的牛血红蛋白分子印迹聚合物. 用红外光谱(IR)、扫描电子显微镜(SEM)和元素分析对聚合物进行了表征, 结果表明, 载体表面成功地接枝了分子印迹聚合物. 选择性吸附实验结果表明, 分子印迹聚合物具有良好的识别性能, 能实现水溶液中牛血红蛋白的富集.     

ADSORPTION OF LDL ON THE MODIFIED CHITOSAN

In this paper,the selective adsorption of LDL on chitosan modified with PEG and Asp.was studied.The adsorption rate of LDL and HDL on the double modified chitosan was 57% and 12% respoectively,The results shown that the double modified chitosan can be used a adsorbent for selective binding to LDL,this work may help to develop functional columns for hemoperfusion.